ALIMONTI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 6.114
AS - Asia 2.622
EU - Europa 2.200
AF - Africa 694
SA - Sud America 677
OC - Oceania 82
Continente sconosciuto - Info sul continente non disponibili 44
Totale 12.433
Nazione #
US - Stati Uniti d'America 5.755
SG - Singapore 781
IT - Italia 749
CN - Cina 513
BR - Brasile 441
HK - Hong Kong 385
VN - Vietnam 153
DE - Germania 132
FI - Finlandia 114
PL - Polonia 112
RU - Federazione Russa 100
NL - Olanda 81
FR - Francia 80
GB - Regno Unito 80
CH - Svizzera 77
SE - Svezia 74
UA - Ucraina 60
KR - Corea 52
AR - Argentina 40
AT - Austria 40
IQ - Iraq 38
ID - Indonesia 33
IE - Irlanda 33
JP - Giappone 33
EC - Ecuador 31
IN - India 31
SA - Arabia Saudita 31
TW - Taiwan 31
PK - Pakistan 30
TR - Turchia 29
UY - Uruguay 29
PH - Filippine 28
RO - Romania 28
TH - Thailandia 27
CU - Cuba 26
DZ - Algeria 26
MA - Marocco 26
PS - Palestinian Territory 26
TN - Tunisia 26
ZA - Sudafrica 26
DK - Danimarca 25
ES - Italia 25
KE - Kenya 25
XK - ???statistics.table.value.countryCode.XK??? 25
BB - Barbados 24
CI - Costa d'Avorio 24
CY - Cipro 24
JM - Giamaica 24
AE - Emirati Arabi Uniti 23
IS - Islanda 23
PA - Panama 23
PE - Perù 23
PY - Paraguay 23
AO - Angola 22
BW - Botswana 22
BY - Bielorussia 22
CA - Canada 22
GT - Guatemala 22
AU - Australia 21
CL - Cile 21
HU - Ungheria 21
IR - Iran 21
JO - Giordania 21
LA - Repubblica Popolare Democratica del Laos 21
LB - Libano 21
MX - Messico 21
PT - Portogallo 21
RS - Serbia 21
AM - Armenia 20
BG - Bulgaria 20
CG - Congo 20
GA - Gabon 20
GR - Grecia 20
ML - Mali 20
NE - Niger 20
AL - Albania 19
BF - Burkina Faso 19
BO - Bolivia 19
CZ - Repubblica Ceca 19
MN - Mongolia 19
MR - Mauritania 19
NP - Nepal 19
RW - Ruanda 19
SI - Slovenia 19
SN - Senegal 19
TZ - Tanzania 19
UZ - Uzbekistan 19
AZ - Azerbaigian 18
BD - Bangladesh 18
BS - Bahamas 18
CR - Costa Rica 18
CW - ???statistics.table.value.countryCode.CW??? 18
DO - Repubblica Dominicana 18
HR - Croazia 18
HT - Haiti 18
KZ - Kazakistan 18
LU - Lussemburgo 18
MD - Moldavia 18
NZ - Nuova Zelanda 18
PR - Porto Rico 18
Totale 11.640
Città #
Fairfield 1.032
Ashburn 520
Singapore 505
Chandler 459
Woodbridge 413
Seattle 386
Hong Kong 365
Houston 350
Cambridge 342
Wilmington 295
Santa Clara 269
Beijing 208
Ann Arbor 158
Boardman 134
Padova 132
San Diego 109
Medford 100
Princeton 100
Bytom 82
Helsinki 77
Milan 76
Des Moines 71
Roxbury 71
Dong Ket 57
Chicago 50
São Paulo 47
Hefei 41
Los Angeles 41
Rome 41
Nanjing 40
Munich 37
Seoul 30
Zurich 27
Dublin 26
Ho Chi Minh City 26
Vienna 26
Havana 24
Bridgetown 23
Nairobi 23
London 22
Montevideo 22
Lugano 21
Panama City 21
Amman 20
Hanoi 20
Yerevan 20
Bamako 19
Dakar 19
Kigali 19
Libreville 19
Shanghai 19
Ulan Bator 19
Abidjan 18
Luanda 18
Niamey 18
Nouakchott 18
Rio de Janeiro 18
Antananarivo 17
Baku 17
Harare 17
Reykjavik 17
Tashkent 17
Turku 17
Dushanbe 16
Gaborone 16
Lilongwe 16
Nassau 16
New York 16
Nuremberg 16
Vientiane 16
Andorra la Vella 15
Bishkek 15
Dar es Salaam 15
Djibouti 15
Guatemala City 15
Kampala 15
Limassol 15
Minsk 15
Pristina 15
Guangzhou 14
Noumea 14
San José 14
Shenyang 14
Bangkok 13
Belo Horizonte 13
Bologna 13
Cayenne 13
Chisinau 13
Dili 13
Hebei 13
Johannesburg 13
Kingston 13
Podgorica 13
Salt Lake City 13
Tirana 13
Belgrade 12
Brooklyn 12
Budapest 12
Conakry 12
Curitiba 12
Totale 7.784
Nome #
A chemogenomic screening identifies CK2 as a target for pro-senescence therapy in PTEN-deficient tumours 258
Anti-senescence activity of Salvia haenkei on skin cellular model identified by integrated senescence-screening assay 240
Cellular Senescence: Aging, Cancer, and Injury 233
Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer 220
Cellular Senescence: Defining a Path Forward 181
Identification of Salvia haenkei as gerosuppressant agent by using an integrated senescence-screening assay 177
Targeting senescence induced by age or chemotherapy with a polyphenol-rich natural extract improves longevity and healthspan in mice 176
CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo 175
Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis 161
Docetaxel in advanced gastric cancer--review of the main clinical trials. 157
Coagulation factor X promotes resistance to androgen-deprivation therapy in prostate cancer 144
High serum levels of TNF-α and IL-6 predict the clinical outcome of treatment with human recombinant erythropoietin in anaemic cancer patients. 143
Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n=4532) 140
Aberrant Rheb-mediated mTORC1 activation and Pten haploinsufficiency are cooperative oncogenic events. 138
Can the reliance of hormone receptor assays of surgical specimens be explained by the fluctuation of estrogen receptor, progesterone receptor, and HER-2 protein expression in tumor samples of premenopausal breast cancer patients? 134
The Akt/mTOR and MNK/eIF4E pathways rewire the prostate cancer translatome to secrete HGF, SPP1 and BGN and recruit suppressive myeloid cells 130
Targeting PML in triple negative breast cancer elicits growth suppression and senescence 129
Epiregulation of the SASP makes good neighbors 124
Non-Cell-Autonomous Regulation of Cellular Senescence in Cancer 123
Interaction of CDCP1 with HER2 Enhances HER2-Driven Tumorigenesis and Promotes Trastuzumab Resistance in Breast Cancer 121
Pro-senescence therapy for cancer: Time for the clinic 121
Re-education of Tumor-Associated Macrophages by CXCR2 Blockade Drives Senescence and Tumor Inhibition in Advanced Prostate Cancer 119
New approaches to prevent intestinal toxicity of irinotecan-based regimens. 118
IL-23 secreted by myeloid cells drives castration-resistant prostate cancer 118
Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer 118
Inhibition of Notch pathway arrests PTEN-deficient advanced prostate cancer by triggering p27-driven cellular senescence 118
MTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer 116
Tumour-infiltrating Gr-1 + myeloid cells antagonize senescence in cancer 116
Erratum to: Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer (Nature Genetics, (2018), 50, 2, (219-228), 10.1038/s41588-017-0026-3) 116
Subacute motor weakness and left renal mass. 114
[Intra-articular treatment with Hylan G-F 20 under ultrasound guidance in hip osteoarthritis. Clinical results after 12 months follow-up]. 114
How phosphorylation influences E1 subunit pyruvate dehydrogenase: A computational study 114
Can colorectal cancer patients with thymidylate synthase-overexpressing liver metastases have an overall survival advantage with hepatic arterial infusion alone? 113
[Safety profile of 185 ultrasound-guided intra-articular injections for treatment of rheumatic diseases of the hip]. 113
Anti-ageing activity of Salvia haenkei in an in vitro epidermal model 113
Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells 112
Molecular pathways: Targeting Tumor-infiltrating myeloid-derived suppressor cells for cancer therapy 111
Subtle variations in Pten dose determine cancer susceptibility 110
Dual functions of SPOP and ERG dictate androgen therapy responses in prostate cancer 110
REL-1017 (Esmethadone) as Adjunctive Treatment in Patients With Major Depressive Disorder: A Phase 2a Randomized Double-Blind Trial 110
Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate. 109
HER2/neu expression and hormonal therapy in early breast cancer: can muddy waters become clear? 109
The potential role of the microbiota in prostate cancer pathogenesis and treatment 108
Long-term follow-up in breast cancer survivors: a single institution survey. 108
Pro-senescence therapy for cancer treatment 108
Zoledronic-acid-induced circulating level modifications of angiogenic factors, metalloproteinases and proinflammatory cytokines in metastatic breast cancer patients 108
Identification of novel therapeutic targets to selectively eliminate senescent cells in prostate cancer. 108
Efficacy and Safety of Esmethadone (REL-1017) in Patients With Major Depressive Disorder and Inadequate Response to Standard Antidepressants: A Phase 3 Randomized Controlled Trial 107
Coral aquaculture to support drug discovery 107
CD38 in Advanced Prostate Cancers 107
18-month observational study on efficacy of intraarticular hyaluronic acid (Hylan G-F 20) injections under ultrasound guidance in hip osteoarthritis]. 106
Enhancing chemotherapy efficacy by reprogramming the senescence-associated secretory phenotype of prostate tumors: A way to reactivate the antitumor immunity 106
Differential p53-independent outcomes of p19(Arf) loss in oncogenesis 106
Senescence Reprogramming by TIMP1 Deficiency Promotes Prostate Cancer Metastasis 105
A multidisciplinary approach for the identification and validation of novel prostate cancer targets - ABSTRACTS OF THE 40TH CONGRESS OF THE ITALIAN PHARMACOLOGICAL SOCIETY (SIF) 105
Genetic and hormonal influence on SARS-CoV-2-infection susceptibility: Re: The potential influence of human Y-chromosome haplogroup on COVID-19 prevalence and mortality 102
Efficacy and safety of viscosupplementation by ultrasound-guided intra-articular injection in osteoarthritis of the hip. 101
Apolipoprotein E induces pathogenic senescent-like myeloid cells in prostate cancer 100
Aging tumour cells to cure cancer: Pro-senescence" therapy for cancer 100
Tumor-infiltrating myeloid cells drive senescence evasion and chemoresistance in tumors 99
In and out from senescence 99
N-methyl-D-aspartate Receptors and Depression: Linking Psychopharmacology, Pathology and Physiology in a Unifying Hypothesis for the Epigenetic Code of Neural Plasticity 98
Prevention of irinotecan plus 5-fluorouracil/leucovorin-induced diarrhoea by oral administration of neomycin plus bacitracin in first-line treatment of advanced colorectal cancer. 98
Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer. 98
A man with a deltoid swelling and paraneoplastic erythrocytosis: case report 98
Does the concurrent use of anthracycline and granulocyte colony-stimulating factor influence the risk of secondary leukaemia in breast cancer women? 98
Open pilot study of ultrasound-guided intra-articular injection of hylan G-F 20 (Synvisc) in the treatment of symptomatic hip osteoarthritis. 97
Potential effect of Salvia Haenkey on in vitro wound healing 96
NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN 95
Identification of novel therapeutic approaches to selectively target senescent cells in prostate cancer 95
Esmethadone-HCl (REL-1017): a promising rapid antidepressant 94
PTEN level in tumor suppression: how much is too little? 94
Incidence of chemotherapy-induced amenorrhea depending on the timing of treatment by menstrual cycle phase in women with early breast cancer. 93
Prostate carcinogenesis: inflammatory storms 93
JMJD6 Is a Druggable Oxygenase That Regulates AR-V7 Expression in Prostate Cancer 93
A new mathematical model based on clinical and laboratory variables for the diagnosis of Sjögren's syndrome. 92
Anti-senescence activity of Salvia Haenkei on a skin cellular model 92
Marine sponge Cribrochalina vasculum compounds activate intrinsic apoptotic signaling and inhibit growth factor signaling cascades in non-small cell lung carcinoma 92
Enhancing chemotherapy efficacy in pten-deficient prostate tumors by activating the senescence-associated antitumor immunity 91
A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis. 90
Viscosupplementation in the management of ankle osteoarthritis: a review. 90
Can we also treat hip osteoarthritis with intra-articular injections of hialuronic acid? Clinical results of 2 year experience using ultrasound guided intra-articular injections 89
The symptomatic effects of intra-articular administration of hylan G-F 20 on osteoarthritis of the hip: clinical data of 6 months follow-up. 87
B7-H3 as a Therapeutic Target in Advanced Prostate Cancer 86
Differential requirement of mTOR in postmitotic tissues and tumorigenesis. 85
Sjögren's syndrome patients with ectopic germinal centers present with a distinct salivary proteome 85
ETS rearrangements and prostate cancer initiation. 82
Identification of a tumour suppressor network opposing nuclear Akt function. 81
Reply to the Letter to the Editor “Androgen deprivation therapy may constitute a more effective prophylactic than therapeutic strategy in COVID-19 patients” by N. Bennani and I. M. Bennani-Baiti 81
Intra-articular administration of hylan G-F 20 in patients with symptomatic hip osteoarthritis: tolerability and effectiveness in a large cohort study in clinical practice. 80
Is thymidylate synthase a reliable predictor for response and survival during hepatic arterial infusion for hepatic metastases from colorectal cancer? 80
Ubiquitination regulates PTEN nuclear import and tumor suppression. 79
Cancer immunotherapy 78
Differential expression of S6K2 dictates tissue-specific requirement for S6K1 in mediating aberrant mTORC1 signaling and tumorigenesis. 77
VSSP-activated macrophages mediate senescence and tumor inhibition in a preclinical model of advanced prostate cancer 75
Generation and validation of in vitro models to study senescence 75
Retrospective Analysis of the Effect of Postmenopausal Women Medications on SARS-CoV-2 Infection Progression 74
Clinical evaluation of the use of exemestane as further hormonal therapy after nonsteroidal aromatase inhibitors in postmenopausal metastatic breast cancer patients. 74
Esmethadone (REL-1017) and Other Uncompetitive NMDAR Channel Blockers May Improve Mood Disorders via Modulation of Synaptic Kinase-Mediated Signaling 71
Identification of novel therapeutic approaches to selectively target senescent cells in prostate cancer 71
Totale 11.203
Categoria #
all - tutte 42.960
article - articoli 40.091
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 387
Totale 83.438


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.094 0 0 0 57 29 50 234 127 140 211 134 112
2021/20221.378 52 167 116 150 62 70 57 127 84 37 75 381
2022/2023907 247 105 58 65 105 81 7 50 90 17 56 26
2023/2024649 40 62 60 52 59 27 66 65 51 19 68 80
2024/20252.787 116 165 145 123 432 81 142 224 239 116 438 566
2025/20263.708 398 966 1.598 746 0 0 0 0 0 0 0 0
Totale 12.576